Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial-Reference-Cited by-同舟云学术

Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial

Published:2014-02 Issue:2 Volume:16 Page:258-265
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Wu Zhixian,Cai Jinquan,Chen Jin,Huang Lianghu,Wu Weizhen,Luo Fang,Wu Chenguang,Liao Lianming,Tan Jianming

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference27 articles.

1. Type 1 and type 2 diabetes: what do they have in common?;Tuomi;Diabetes,2005

2. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1;Miyata;J Clin Invest,1994

3. Extrinsic regulation of pluripotent stem cells;Pera;Nature,2010

4. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice;Beilhack;Diabetes,2003

5. Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus;Estrada;Cell Transplant,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous intraarterial pancreatic bone-marrow mononuclear cells infusion in T2D patients: Changes on beta-cells function, insulin resistance, and inflammatory marker;Current Research in Translational Medicine;2024-06

2. Mesenchymal Stem/Stromal Cells Therapy for Metabolic Syndrome: Potential Clinical Application?;Stem Cells;2023-07-05

3. Effectiveness and safety of stem cells in the treatment of diabetes;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2022-12-27

4. Clinical efficacy of stem-cell therapy on diabetes mellitus: A systematic review and meta-analysis;Transplant Immunology;2022-12

5. Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes;Stem Cells International;2022-08-22